#22 SPECIAL EDITION - Zolgensma (AVXS - 101) Under Priority FDA Review

#22 SPECIAL EDITION - Zolgensma (AVXS - 101) Under Priority FDA Review

SMA News Today Forums & Multimedia Director Michael Morale discusses the breaking news Zolgensma (AVXS-101) Under Priority FDA Review as Possible Gene Therapy for SMA Type 1. Read the full report here: https://smanewstoday.com/2018/12/04/zolgensma-avxs-101-under-priority-fda-review-as-possible-gene-therapy-for-sma-type-1/

Populært innen Helse

fastlegen
lydartikler-fra-aftenposten
psykodrama
rss-gukild-johaug
hvordan-har-du-det-mann
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-garne-damer
morten-ramm-lar-kakla-ga-til-du-sovner
foreldreradet
fryktlos
baarli-og-benjamin-gar-i-terapi
hormonelle-frida
klimaks
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
hjernesterk
rss-podkasten-lopeklubben
helsetipspodden
rss-baarli-og-benjamin-gar-i-terapi
rss-sunn-okonomi